These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


397 related items for PubMed ID: 34875999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Jiao-tai-wan and its effective component-coptisine alleviate cognitive impairment in db/db mice through the JAK2/STAT3 signaling pathway.
    Nie K, Gao Y, Wang H, Su H, Chen S, Jiang X, Dong H, Tang Y.
    Phytomedicine; 2024 Nov; 134():155954. PubMed ID: 39178683
    [Abstract] [Full Text] [Related]

  • 4. Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP/PKA/CREB signaling pathway.
    Tang Y, Gao Y, Nie K, Wang H, Chen S, Su H, Huang W, Dong H.
    J Ethnopharmacol; 2024 Apr 24; 324():117829. PubMed ID: 38296172
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-depressive effects of Jiao-Tai-Wan on CORT-induced depression in mice by inhibiting inflammation and microglia activation.
    Bai G, Qiao Y, Lo PC, Song L, Yang Y, Duan L, Wei S, Li M, Huang S, Zhang B, Wang Q, Yang C.
    J Ethnopharmacol; 2022 Jan 30; 283():114717. PubMed ID: 34627986
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Network pharmacology analysis revealed the mechanism and active compounds of jiao tai wan in the treatment of type 2 diabetes mellitus via SRC/PI3K/AKT signaling.
    Ye C, Li Y, Shi J, He L, Shi X, Yang W, Lei W, Quan S, Lan X, Liu S.
    J Ethnopharmacol; 2025 Jan 30; 337(Pt 2):118898. PubMed ID: 39374878
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H, Tan H, Zhan W, Song L, Zhang D, Chen X, Lin Z, Wang W, Yang Y, Wang L, Bei W, Guo J.
    J Ethnopharmacol; 2021 Jun 28; 274():114056. PubMed ID: 33771638
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.
    Wang W, Zhao L, He Z, Wu N, Li Q, Qiu X, Zhou L, Wang D.
    J Ethnopharmacol; 2018 Jun 12; 219():299-318. PubMed ID: 29580854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uncovering the active components, prospective targets, and molecular mechanism of Baihe Zhimu decoction for treating depression using network pharmacology-based analysis.
    Wang HQ, Liu HT, Wang L, Min L, Chen B, Li H.
    J Ethnopharmacol; 2021 Dec 05; 281():114586. PubMed ID: 34464700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Berberine exerts antidepressant effects in vivo and in vitro through the PI3K/AKT/CREB/BDNF signaling pathway.
    Tang Y, Su H, Nie K, Wang H, Gao Y, Chen S, Lu F, Dong H.
    Biomed Pharmacother; 2024 Jan 05; 170():116012. PubMed ID: 38113631
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.